Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model | Antimicrobial Agents and Chemotherapy
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans | Scientific Reports
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice | PNAS
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology
Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model
JCI Insight - Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial Agents and Chemotherapy
Effect of niacin supplementation on nausea-like behaviour in an isoniazid-induced mouse model of pellagra | British Journal of Nutrition | Cambridge Core
pH‐Responsive Isoniazid‐Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice - Hwang - 2015 - Small - Wiley Online Library
Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid | Nature Communications
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model | Antimicrobial Agents and Chemotherapy
Epidemiology in History Ficacy, Effectiveness, Toxicity, Durability, and Duration | PDF | Tuberculosis | Hiv/Aids
A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis | Nature Communications
Isoniazid | 99.9%(HPLC) | In Stock | Fatty Acid Synthase inhibitor
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice | PNAS
Hepatoprotective effects of Malus hupehensis tea against isoniazid- and rifampicin-induced liver injury by regulating cytochrome P450 in mice - ScienceDirect
Treatment of Tuberculosis Using a Combination of Sustained-Release Rifampin-Loaded Microspheres and Oral Dosing with Isoniazid | Antimicrobial Agents and Chemotherapy
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats | Chemical Research in Toxicology
Isoniazid Oral Solution - CMP Pharma
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy | Antimicrobial Agents and Chemotherapy
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial - ScienceDirect
